We serve Chemical Name:(2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine CAS:118535-61-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine
CAS.NO:118535-61-8
Synonyms:(S)-(-)-1-Amino-2-(1‘-methoxy-1‘-methylethyl)pyrrolidine;(S)-2-(2-Methoxypropan-2-yl)pyrrolidin-1-amine
Molecular Formula:C8H18N2O
Molecular Weight:158.24100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:210.2ºC at 760mmHg
Density:N/A
Index of Refraction:1.467-1.469
PSA:38.49000
Exact Mass:158.14200
LogP:1.38770
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (S)-(-)-1-Amino-2-(1‘-methoxy-1‘-methylethyl)pyrrolidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-2-(2-Methoxypropan-2-yl)pyrrolidin-1-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-(-)-1-Amino-2-(1‘-methoxy-1‘-methylethyl)pyrrolidine Use and application,(S)-2-(2-Methoxypropan-2-yl)pyrrolidin-1-amine technical grade,usp/ep/jp grade.
Related News: Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData��s Company Financials database. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine manufacturer But even though weight-loss success depends on adopting a challenging” change in post-operation diet and lifestyle, the process can certainly “help people to lose weight and get comorbid [other negative health] conditions under better control,” Sandon said.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine supplier At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine vendor The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine factory At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries.
So it’s important, she said, to help eligible patients better “understand the treatment options and potential for success,” by sharing surgery success stories and highlighting the benefits of reducing high-risk health issues such as blood pressure and diabetes.
An experimental Alzheimer’s vaccine appears to safely clear abnormal tau protein from the brain, but it’s not yet clear whether the shot will be able to save brain function.
In a Phase 2 clinical trial, the vaccine produced high levels of antibodies to target and attack free-floating tau proteins before they can form “tau tangles” that clog neurons and damage brain function. Tau tangles, along with plaques formed by the protein amyloid-beta, serve as one of the main hallmarks of Alzheimer’s.
“While amyloid influences speed of Alzheimer’s progression, there is strong evidence that tau pathology relates to the underlying cause of the disease,” said lead researcher Dr. Petr Novak, a senior clinical research scientist at AXON Neuroscience, the Slovakian pharmaceutical company developing the vaccine. “Brain atrophy and cognitive loss closely echo the deposition of pathological tau protein, as evidenced by recent tau PET studies. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine supplier At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine vendor The United Kingdom, for instance, is now warning against all but essential travel to mainland China, and is advising against all travel to Hubei province, where the outbreak was first reported. (2S)-2-(2-methoxypropan-2-yl)pyrrolidin-1-amine factory At present, Linhai, Zhejiang Province, has established a national chemical raw material base in Zhejiang Province, which is the earliest and largest gathering area of ??domestic chemical raw material medicines and pharmaceutical intermediate industries.
